Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …

Introduction Neo/adjuvant therapy for early-stage breast cancer has become increasingly
common in the last few decades; as a consequence, the number of breast cancer survivors …

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment
ends and may lead to functional decline and falls. This study compared objective and self …

Cancer diagnosis and treatment are drastic events for patients and their families. Besides
psychological aspects of the disease, patients are often affected by severe side effects …

Background Chemotherapy‐induced peripheral neuropathy (CIPN) is one of the most
debilitating long‐term side effects in breast cancer survivors. We conducted a randomized …

Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy
that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by …

Background Combinations of exercise and nutritional interventions might improve the
functional prognosis for cachectic cancer patients. However, high attrition and poor …

We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information …

Background: Most individuals affected by cancer who are treated with certain
chemotherapies suffer of CIPN. Therefore, there is a high patient and provider interest in …

Purpose Summarize and critically evaluate the existing studies to determine the effects of
exercise on chemotherapy-induced peripheral neuropathy in cancer patients. Methods We …